-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33

Benzinga·08/11/2026 19:32:56
Listen to the news
Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and lowers the price target from $35 to $33.